Cord blood banking is a once-in-a lifetime opportunity to be prepared for the future of medicine. Umbilical cord stem cells are a potentially lifesaving resource for your child, their siblings, and other family members.
Most of the diseases for which umbilical cord blood is a standard treatment are disorders of blood cell lineage, such as blood cancers, tumors, and other disorders. The hematopoietic stem cells in umbilical cord blood are used to rebuild the body following chemotherapy and other aggressive treatments. Currently, there are over 80 FDA approved treatments using umbilical cord blood, including childhood leukemia, sickle cell anemia, and other blood cancers and immune disorders.
Unlike that of older children and adults, newborn umbilical cord blood contains important baseline genetic information without the influence of environmental factors. This baseline genetic information can be compared later in life to determine if there have been changes caused by environmental factors. It can provide valuable insights into understanding the influence of food, drugs, stress, or exposure to toxins on how genes function and what treatment options are available.
Using only a small portion of the stem cells you stored with us, your medical professional can use your newborn’s stem cells for genetic analysis. They would simply contact us to request a small sample of your child’s stem cells for DNA analysis and our team will have it processed and shipped to them.
Other family members may also be able to take advantage of the potentially lifesaving benefits of your newborn’s cord blood. Children with the same biological parents have a 25% chance of being a perfect HLA (Human Leukocyte Antigens) match and a 50% chance of being a partial HLA match. Human Leukocyte Antigens are proteins that your immune system uses to recognize which cells belong in your body and which do not.
Parents and grandparents may also be able to use your newborn’s cord blood for certain therapies. Future uses could include treatment for Alzheimer’s Disease, currently being explored in clinical trials.
In thinking about banking your newborn’s umbilical cord blood, an important consideration is how long it will be a potential lifesaving resource. Stem cells have been safely stored and used after 25 years.
Keep in mind that just like any other drug, the amount you need depends on your child’s weight and on the disease being treated. The National Cord Blood Program at the New York Blood Center suggests an average stem cell count for an umbilical cord transplant should be a minimum of 2×107 Total Nucleated Cells (TNCs) per kg of body weight.
The time period for using your child’s cord blood depends on the number of stem cells in their cord blood collection – the more stems cells extracted, the longer your child can use them. That’s why it’s important to bank with Cord for Life®, the only cord blood bank with PREMIERMAXCB ® technology, clinically proven process to yield the highest number of stem cells.
Reserve your Cord Blood Collection Kit in time to bring it with you when you go into labor. Give your newborn every advantage with cord blood banking!
By donating your newborn’s cord blood, you are joining a nationwide effort to create a genetically diverse inventory of stem cells for transplant to a child.
Ms. Sardone has over 30 years of clinical laboratory experience as a Clinical Laboratory Technologist and Supervisor, including over 25 years with Central Florida Regional Hospital (CFRH). She was Supervisor of Quality Assurance, Safety and Education at CFRH for 11 years, held the positions of Blood Bank Supervisor for 11 years, and Hematology Supervisor for 1 year. She has participated in both sides of the inspection process, serving on the College of American Pathologists Inspection team for CAP Hospital Accreditation in Florida, and assisting in receiving accreditation by The Joint Commission (TJC), American Association of Blood Banks (AABB), and Food and Drug Administration (FDA) through the inspections of the clinical laboratory. Ms. Sardone is licensed by the State of Florida as a Clinical Laboratory Technologist in Immunohematology, Hematology, Serology and Clinical Chemistry. She is a certified Clinical Laboratory Technologist with the American Society of Clinical Pathologists (ASCP). Ms. Sardone serves as Manager of Quality Assurance and Regulatory Affairs at Cord For Life, Inc. overseeing all licensing and regulatory agencies to ensure that the highest quality in all aspects of cord blood collection, processing, and storage is maintained. Ms. Sardone has been with Cord For Life for over 5 years of dedicated service. Her skills and knowledge in blood banking and quality assurance have enabled her to establish, implement and maintain a superior quality system that meets and exceeds all standards and regulatory requirements for Cord For Life, Inc.
Ms. Cable has 35+ years – experience in Office, Management, Human Resources, & Customer Service. As the Director of Administration and Client Services, Ms. Cable joined Cord for Life in December 2006, and has assisted in providing more efficient and effective ways to ease the enrollment process, as well as obtaining and establishing excellent customer care during the enrollment and donation period; for our Storage and Donation customers.
Mr. Hudspeth has over 28 years of clinical laboratory experience as a certified Medical Technologist (ASCP), including ten years with the University of North Carolina Hospitals and 18 years with Cord for Life. Mr. Hudspeth is licensed by the State of Florida as a Clinical Laboratory Supervisor in Immunohematology, Hematology, Serology, Clinical Chemistry, Molecular Pathology and Microbiology as well as a Clinical Laboratory Scientist and has completed the AABB Certification in Cellular Therapies through George Washington University.
Mr. Hudspeth is a registered Technologist with the American Society of Clinical Pathologists and a member of the Cord Blood Association. He has also enjoyed teaching Immunology to Clinical Laboratory Science and medical school students at UNC while working in the UNCH clinical labs. Mr. Hudspeth is an Eagle Scout with 5 palms and has served numerous volunteer positions within the local Scouts BSA Troop and Pack.
During the last two years of Medical School, Dr. Irrgang was in the United States Navy 1915 Ensign Program and completed a clerkship at the Naval Hospital at Charleston, South Carolina as well as a research clerkship at the Naval Aerospace Institute at Pensacola, Florida. Dr. Irrgang completed her four year Pathology residency at Baylor University Medical Center, and her internship at the University District Hospital, Rio Piedras in San Juan, Puerto Rico.
Currently, Dr. Irrgang is Board Certified in Anatomic and Clinical Pathology and licensed in the states of South Carolina, Texas, New Jersey and Florida and she is an Associate Medical Examiner at the District Nine Medical Examiners Office. Dr. Irrgang is a fellow at numerous organizations including; The College of American Pathologists, National Association of Medical Examiners, Florida Association of Medical Examiners, Seminole County Medical Society, and the Florida Medical Society.